M-606

N/A

Report date: 2025/01/26 15:51:25
NME

Base Information

Drug NameM-606
Drug Alias NameMYCN gene inhibitors (Children's Cancer Institute Australia for Medical Research/Cleveland BioLabs)MYCN gene inhibitors (Children's Cancer Institute Australia for Medical Research/Statera Biopharma)N-myc gene inhibitors (Children's Cancer Institute Australia for Medical Research/Cleveland BioLabs)M-606
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-myc proto-oncogene protein inhibitors
TargetsN-myc proto-oncogene protein
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChildrens Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesStatera Biopharma IncChildrens Cancer Institute
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A